KEELY COOK: Open Payments
NPI 1225154743 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,079 in 59 payments from 12 companies in 2025. Trend: 2023 $96 · 2024 $185 · 2025 $2,079
Food & beverage: $2,079
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $535 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $394 |
| Janssen Biotech, Inc. | 6 | $320 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $168 |
| Phathom Pharmaceuticals, Inc. | 3 | $152 |
| Madrigal Pharmaceuticals | 1 | $140 |
| PFIZER INC. | 6 | $109 |
| Ardelyx, Inc. | 4 | $91 |
| GENZYME CORPORATION | 3 | $83 |
| Novo Nordisk Inc | 2 | $45 |
Products named: ENTYVIO, TREMFYA, SKYRIZI, RINVOQ, XIFAXAN, VOQUEZNA, REZDIFFRA, VELSIPITY.
Industry payments across FL — which companies pay providers there.
